David Lamadrid insider trades: Cytosorbents (CTSO) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 6, 2011 | CTSO | ↓ Sell10b5-1 | 12,500 | $0.21 | $3K | Direct | Sep 9, 2011 (3d) |
| Nov 20, 2009 | MSBT | ↓ Sell | 505,000 | $0.17 | $87K | Direct | Nov 24, 2009 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CTSO insiders
Open-market trades in the last 12 months
About David Lamadrid's insider trades
David Lamadrid is Chief Financial Officer at Cytosorbents (CTSO). Since Nov 20, 2009, David has reported no open-market purchases and 2 sales worth $90K on SEC Form 4. There have been no open-market trades in the last 12 months.
1 sale (3% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include grants and awards (9 filings), other transactions (2 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CTSO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.